Thus, a loss of E-cadherin expression in NSCLC appears to be predictive of poor responsiveness to EGFR- and ALK-TKIs and is characteristic of EMT induction in NSCLCs that become resistant to these drugs. Here, ALK is linked to non-small cell lung carcinoma.